Search results

Evidence-based recommendations on photodynamic therapy for brain tumours. This involves giving the patient a drug that makes the tissue sensitive to light and then activating it with a laser light source to destroy the tumour cells.

Result type

Interventional procedures guidance

Published

25 March 2009

Evidence-based recommendations on laparoscopic deroofing of simple renal cysts. This involves draining the cyst and removing part of the cyst wall through small cuts in the abdomen (keyhole surgery).

Result type

Interventional procedures guidance

Published

25 July 2007

Evidence-based recommendations on bevacizumab (Avastin), with other drugs, for treating metastatic colorectal cancer in adults.

Result type

Technology appraisal guidance

Published

15 December 2010

Evidence-based recommendations on bevacizumab (Avastin) and cetuximab (Erbitux) for treating metastatic colorectal cancer in adults.

Result type

Technology appraisal guidance

Last updated

1 January 2012

Evidence-based recommendations on Virtual Touch Quantification to diagnose and monitor liver fibrosis in chronic hepatitis B and C.

Result type

HealthTech guidance

Last updated

17 January 2020

Evidence-based recommendations on minimally invasive video-assisted thyroidectomy. This involves inserting instruments through a small cut (keyhole surgery) to remove part or all of the gland.

Result type

Interventional procedures guidance

Published

23 August 2014

Evidence-based recommendations on cryotherapy for treating recurrent prostate cancer. This involves putting special needles or probes into the prostate and using Argon gas to freeze and destroy the cancerous prostate tissue.

Result type

Interventional procedures guidance

Published

25 May 2005

Evidence-based recommendations on topotecan, pegylated liposomal doxorubicin hydrochloride (Caelyx; PLDH), paclitaxel, trabectedin (Yondelis) and gemcitabine. These drugs are for people with ovarian cancer that has come back some time after it was first treated.

Result type

Technology appraisal guidance

Published

27 April 2016

Evidence-based recommendations on testing for epidermal growth factor receptor tyrosine kinase (EGFR–TK) mutations in untreated, locally advanced or metastatic non-small-cell-lung cancer.

Result type

HealthTech guidance

Published

14 August 2013

Comes from guidance Axitinib for treating advanced renal cell carcinoma after failure of prior systemic treatment Number TA333

Result type

Research recommendation

Published

9 June 2015

Evidence-based recommendations on irreversible electroporation (IRE) for treating renal cancer. This involves using electrical pulses to kill cancer cells, applied directly to the tumour through special needles.

Result type

Interventional procedures guidance

Published

23 February 2013

Discontinued Reference number: GID-TAG407

Result type

Technology appraisal guidance

Status

Discontinued

Evidence-based recommendations on melphalan chemosaturation with percutaneous hepatic artery perfusion and hepatic vein isolation for primary or metastatic cancer in the liver. This involves diverting the blood flow from the liver to the rest of the body while the drug is delivered directly into the liver.

Result type

Interventional procedures guidance

Published

21 April 2021

Discontinued Reference number: GID-TA10841

Result type

Technology appraisal guidance

Status

Discontinued

Evidence-based recommendations on Ambulight PDT for the treatment of non-melanoma skin cancer.

Result type

HealthTech guidance

Published

25 July 2011